Skip to content

Research and development of key technologies for precise prevention and treatment of type 1 diabetes based on gene-environment interaction - to screen high-risk groups for type 1 diabetes

Research and development of key technologies for precise prevention and treatment of type 1 diabetes based on gene-environment interaction - to screen high-risk groups for type 1 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097745
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 1

Interventions

Case group:None
Control group:None

Sponsors

Children's Hospital,Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study intends to include the diabetic population and high-risk groups who are outpatient and inpatient in our hospital, the Obstetrics and Gynecology Hospital of Zhejiang University, the Shaw Hospital of Zhejiang University, Zhejiang Provincial People's Hospital, the First People's Hospital of Hangzhou, the Women and Children's Hospital of Ningbo University, and the Second Affiliated Hospital of Wenzhou Medical University from January 2024 to December 2025. 1. Inclusion Criteria for Diabetes Group: (All of the following items must be met) (1) Children with a new diagnosis of T1D (2) Children with a new diagnosis of T1D and their first-degree relatives. 2. Inclusion criteria for non-diabetic control population: children and their first-degree relatives, including blood glucose, insulin, glycosylated hemoglobin and other indicators within the normal range. 3. Inclusion criteria for the biochemical analysis group: (1) patients diagnosed with T1D (2) high-risk groups in children, including: grade 1 relatives with a history of diabetes, the general population with both genetic high-risk factors and environmental high-risk factors screened by high-risk factor scores in the diabetes control study (3) people who have tested positive for antibodies but have normal blood glucose.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for non-diabetic control populations (any of the following items can be excluded): any patients with abnormal blood glucose or a history of autoimmune disease. 2. Biochemical analysis group exclusion criteria (any of the following items can be excluded): have other chronic diseases or birth defects, are unable to have long-term follow-up or are using treatments that may affect blood glucose (such as steroids)..

Design outcomes

Primary

MeasureTime frame
Genetic locus of high risk for type 1 diabetes;Environmental factors at high risk for type 1 diabetes;

Secondary

MeasureTime frame
Active metabolites associated with type 1 diabetes;

Countries

China

Contacts

Public ContactWu Wei

Children's Hospital,Zhejiang University School of Medicine

wuwei120@zju.edu.cn+86 136 6664 5030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026